Latest filing published 15 Jun 2022 for Enzo Biochem INC, €7,207.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
David Bench: trading record in brief
David Bench is a declared insider of Enzo Biochem Inc (finance chief), with filings sourced from SEC (Form 4). Between 13 April 2022 and 14 June 2022, the trades on record add up to 3 filings.
On the market, this insider has only ever bought: 1 purchase, €7,207 in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 2 share grants.
The newest entry dates from 15 June 2022: an open-market purchase of €7,207, in Enzo Biochem Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to David Bench
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,500 shares@ US$2.1562.4% of flowCommon Stock, $0.01 Par ValueSEC:0001213900-22-033077:0Canonical exit: 12 Sept 2022 (T+90)
- 1,620 shares@ US$2.9037.6% of flowCommon Stock, $0.01 Par ValueSEC:0001213900-22-019913:0
2 of 2 declarations
